id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2021-E-0381-0004,FDA,FDA-2021-E-0381,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2021-10-12T04:00:00Z,2021,10,2021-10-12T04:00:00Z,,2021-10-12T17:49:37Z,,0,0,0900006484dc278c
FDA-2021-E-0381-0003,FDA,FDA-2021-E-0381,Letter to U S Patent and Trademark Office,Other,Letter(s),2021-06-08T04:00:00Z,2021,6,2021-06-08T04:00:00Z,,2021-06-08T15:04:08Z,,0,0,0900006484b5d51b
FDA-2021-E-0381-0002,FDA,FDA-2021-E-0381,"Patent Extension Application from Oblon, McClelland, Maier & Neustadt, P.C. (on behalf of Kyushu University, National University Corporation)",Other,Application,2021-04-13T04:00:00Z,2021,4,2021-04-13T04:00:00Z,,2021-04-13T14:29:03Z,,0,0,0900006484aa4ebc
FDA-2021-E-0381-0001,FDA,FDA-2021-E-0381,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2021-04-13T04:00:00Z,2021,4,2021-04-13T04:00:00Z,,2021-04-13T14:28:48Z,,0,0,0900006484aa4eba